Multiple myeloma |
miR-135b |
promotes neoangiogenesis in the primary tumor |
Umezu et al. [29] |
Breast cancer |
miR122 |
↓ glucose uptake of normal brain cells |
Fong et al. [40] |
Normal astrocytic cells |
PTEN targeting miR19a |
↓ PTEN expression in brain metastatic tumor cells |
Zhang et al. [44] |
Non-small cell lung cancer |
lnc-MMP2-2 |
destroys the tight junctions of the BBB |
Wu et al. [48] |
Breast cancer |
microRNA 181c |
destroys the BBB by modulating the actin dynamics |
Tominaga et al. [53] |
Breast cancer |
miR105 |
destroys the endothelial cell barrier by down-regulating ZO-1 tight junctions |
Lokody et al. [55] |
Breast cancer |
lncRNA GS1-600G8.5 |
disrupts the BBB by targeting the tight junction proteins |
Lu et al. [57] |
Breast cancer |
miR-503 |
induces the release of tumoral growth factors and microglial reprograming leading to immune suppression |
Xing et al. [58] |
Lung cancer |
Vimentin |
vimentin expression ↑ in the metastatic stage and induces epithelial–mesenchymal transition |
Rahman et al. [15] |
Lung and breast cancer |
CEMIP |
induces a proinflammatory vascular niche, promoting metastasis |
Rodrigues et al. [59] |
Lung cancer SCLC |
S100A16 |
improves the survival of SCLC metastatic cells inside the cerebrum |
Xu et al. [46] |
Lung cancer, breast cancer, colorectal cancer, melanoma, pancreatic cancer, gastroesophageal cancer, bladder cancer |
RNU6-1 |
regulates tumoral growth rate |
Puigdelloses et al. [61] |